Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kobold Capital is a venture capital firm established to focus on life sciences and emerging medical technologies. Founded in Australia, the firm aims to identify and capitalize on high-value opportunities in both public and private life sciences companies. The organization has a clear commitment to investing in sectors that promise significant advancements and returns.
Currently, Kobold Capital manages a portfolio of four companies, reflecting its targeted approach to investment. The firm operates across various stages, including pre-seed, seed, Series A, and pre-IPO, allowing it to engage with startups at different points in their growth trajectories. This flexibility enhances its ability to support innovative companies as they scale.
With a focus on high-impact investments, Kobold Capital is well-positioned to leverage its expertise in identifying opportunities that can lead to exponential growth. The firm’s strategic location in Australia provides it with unique insights into the local and regional markets, further enhancing its investment capabilities.
Kobold Capital invests primarily in life sciences, greentech, deep tech, and artificial intelligence. The firm targets investments that demonstrate the potential for exponential growth or are approaching significant value inflection points. This investment strategy encompasses both private and public investments, including pre-IPO and early-stage seed rounds.
The firm emphasizes high-impact opportunities, seeking to partner with companies that are at the forefront of technological advancements in their respective fields. Kobold Capital's approach is characterized by a thorough analysis of market trends and the identification of startups that align with its investment thesis.
In addition to its sector focus, Kobold Capital values founders who demonstrate a strong vision and the capability to execute their business plans effectively. The firm is open to various deal structures and often collaborates with other investors to maximize the potential of its portfolio companies.
Kobold Capital has a notable track record of investing in early-stage life sciences and technology companies. Its current portfolio includes:
These companies exemplify Kobold Capital's commitment to investing in sectors that are poised for growth and innovation. The firm actively seeks to support its portfolio companies through various stages of development, ensuring they have the resources needed to succeed.
Damian Slizys - Principal. Damian has extensive experience in venture capital and has led multiple successful investments in the life sciences sector.
Julian Chick - Principal. Julian brings a strong background in technology investments, focusing on deep tech and AI-driven companies.
Ryder Widdowson - Principal. Ryder specializes in healthcare investments and has a proven track record of supporting startups in the biotech space.
Submit your pitch through their website contact form for consideration.
As of October 2023, Kobold Capital continues to actively invest in early-stage life sciences and technology companies. The firm has recently highlighted its commitment to identifying high-value opportunities in both public and private sectors.
Recent updates on their website indicate ongoing efforts to expand their portfolio and support innovative startups in the biotech and AI sectors.
What are Kobold Capital's investment criteria?
Kobold Capital focuses on life sciences, greentech, deep tech, and artificial intelligence. The firm looks for companies with potential for exponential growth or those nearing significant value inflection points.
How can startups apply or pitch to Kobold Capital?
Startups interested in pitching to Kobold Capital should reach out through their website. A well-prepared pitch deck that outlines the business model, market opportunity, and team is essential.
What makes Kobold Capital different from other venture capital firms?
Kobold Capital specializes in high-impact investments within life sciences and emerging technologies, providing targeted expertise and resources to its portfolio companies.
What is the geographic scope of Kobold Capital's investments?
The firm primarily invests in Australia and the Oceania region, focusing on local and regional startups that align with its investment thesis.
What is Kobold Capital's approach to post-investment involvement?
Kobold Capital actively engages with its portfolio companies, offering operational support and strategic guidance to help them navigate growth challenges.
What is the typical check size for investments made by Kobold Capital?
The firm invests across various stages, including pre-seed, seed, Series A, and pre-IPO, with check sizes varying based on the specific opportunity and company needs.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.